Amanote Research
Register
Sign In
Interruption of CCL2 Inhibition Enhances Metastatic Disease
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2014-226
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
October 30, 2014
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Inhibition of miR-34b and miR-34c Enhances Α-Synuclein Expression in Parkinson's Disease
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics
Inhibition of Stathmin1 Accelerates the Metastatic Process
Cancer Research
Cancer Research
Oncology
Endobronchial Metastatic Disease.
Thorax
Pulmonary
Respiratory Medicine
The CCL2/CCR2 Axis Enhances Vascular Cell Adhesion Molecule-1 Expression in Human Synovial Fibroblasts
PLoS ONE
Multidisciplinary
SABR Combats Metastatic Disease
Cancer Discovery
Oncology
Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition
Molecular Cancer Therapeutics
Cancer Research
Oncology
Retrospective Analysis of HER2 Therapy Interruption in Patients Responding to the Treatment in Metastatic HER2+ Breast Cancer
ESMO Open
Cancer Research
Oncology
WNT Inhibition Enhances Browning of Mouse Primary White Adipocytes
Adipocyte
Histology
Cell Biology
The Science of Interruption
BMJ Quality and Safety
Medicine
Health Policy